Correlation Between Timber Pharmaceuticals and Ascletis Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Timber Pharmaceuticals and Ascletis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Timber Pharmaceuticals and Ascletis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Timber Pharmaceuticals and Ascletis Pharma, you can compare the effects of market volatilities on Timber Pharmaceuticals and Ascletis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Timber Pharmaceuticals with a short position of Ascletis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Timber Pharmaceuticals and Ascletis Pharma.

Diversification Opportunities for Timber Pharmaceuticals and Ascletis Pharma

0.56
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Timber and Ascletis is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Timber Pharmaceuticals and Ascletis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascletis Pharma and Timber Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Timber Pharmaceuticals are associated (or correlated) with Ascletis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascletis Pharma has no effect on the direction of Timber Pharmaceuticals i.e., Timber Pharmaceuticals and Ascletis Pharma go up and down completely randomly.

Pair Corralation between Timber Pharmaceuticals and Ascletis Pharma

If you would invest  15.00  in Ascletis Pharma on August 31, 2024 and sell it today you would earn a total of  3.00  from holding Ascletis Pharma or generate 20.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy1.59%
ValuesDaily Returns

Timber Pharmaceuticals  vs.  Ascletis Pharma

 Performance 
       Timeline  
Timber Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Timber Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Timber Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Ascletis Pharma 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ascletis Pharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting essential indicators, Ascletis Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Timber Pharmaceuticals and Ascletis Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Timber Pharmaceuticals and Ascletis Pharma

The main advantage of trading using opposite Timber Pharmaceuticals and Ascletis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Timber Pharmaceuticals position performs unexpectedly, Ascletis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascletis Pharma will offset losses from the drop in Ascletis Pharma's long position.
The idea behind Timber Pharmaceuticals and Ascletis Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Share Portfolio
Track or share privately all of your investments from the convenience of any device